ZA891653B - Porphyrins and cancer treatment - Google Patents

Porphyrins and cancer treatment

Info

Publication number
ZA891653B
ZA891653B ZA891653A ZA891653A ZA891653B ZA 891653 B ZA891653 B ZA 891653B ZA 891653 A ZA891653 A ZA 891653A ZA 891653 A ZA891653 A ZA 891653A ZA 891653 B ZA891653 B ZA 891653B
Authority
ZA
South Africa
Prior art keywords
porphyrins
cancer treatment
same
compound
compounds
Prior art date
Application number
ZA891653A
Other languages
English (en)
Inventor
Raymond Bonnett
Bonnett Raymond
Morris Cyril Berenbaum
Cyril Berenbaum Morris
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of ZA891653B publication Critical patent/ZA891653B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA891653A 1988-03-11 1989-03-03 Porphyrins and cancer treatment ZA891653B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805849A GB8805849D0 (en) 1988-03-11 1988-03-11 Porphyrins & cancer treatment

Publications (1)

Publication Number Publication Date
ZA891653B true ZA891653B (en) 1989-11-29

Family

ID=10633278

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891653A ZA891653B (en) 1988-03-11 1989-03-03 Porphyrins and cancer treatment

Country Status (17)

Country Link
US (1) US4992257A (fr)
EP (1) EP0337601B1 (fr)
JP (1) JP2785033B2 (fr)
KR (1) KR970011392B1 (fr)
AT (1) ATE89002T1 (fr)
AU (1) AU611774C (fr)
BR (1) BR1100662A (fr)
CA (1) CA1338737C (fr)
DE (2) DE68906301T2 (fr)
ES (1) ES2055038T3 (fr)
GB (1) GB8805849D0 (fr)
HK (1) HK129693A (fr)
IE (1) IE63290B1 (fr)
LU (1) LU90907I2 (fr)
NL (1) NL300089I2 (fr)
NZ (1) NZ228225A (fr)
ZA (1) ZA891653B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162519A (en) * 1988-03-11 1992-11-10 Efamol Holdings Plc Porphyrins and cancer treatment
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US6362175B1 (en) 1991-09-20 2002-03-26 The Trustees Of The University Of Pennsylvania Porphyrin compounds for imaging tissue oxygen
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
ATE189966T1 (de) * 1992-11-20 2000-03-15 Univ British Columbia Aktivierung von photoempfindlichen mitteln
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
JPH07233065A (ja) * 1993-12-27 1995-09-05 Canon Inc ピリリウム塩又はピリリウム類似塩を含む光化学治療薬
GB9408746D0 (en) * 1994-05-03 1994-06-22 Scotia Holdings Plc Tumour locallising photosensitising compounds
WO1996009053A1 (fr) * 1994-09-20 1996-03-28 Duke University Activite d'oxydoreductase de porphyrines manganiques
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
IL122451A0 (en) * 1995-06-07 1998-06-15 Univ Duke Oxidant scavengers
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
DE69718268D1 (de) 1996-10-03 2003-02-13 Canon Kk Verfahren zur Detektion von Zielnukleinsäure, Verfahren zu ihrer Quantifizierung und Pyrylium-Verbindungen zur Chemilumineszenz-Analyse
US6582392B1 (en) 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
IL135949A0 (en) 1997-11-03 2001-05-20 Univ Duke Substituted porphyrins
DE19814405C2 (de) 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
AU771259B2 (en) 1998-04-24 2004-03-18 Aeolus Sciences, Inc. Substituted porphyrins
DE69922216T2 (de) * 1998-08-28 2005-12-01 Destiny Pharma Ltd. Porphyrin derivate, ihre verwendung in der photodynamischen therapie und diese enthaltende medizinische geräte
DK1616869T3 (da) 1999-01-25 2012-05-07 Nat Jewish Health Substituerede porphyriner og deres terapeutiske anvendelse
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
GB0001455D0 (en) * 2000-01-21 2000-03-15 Scotia Holdings Plc Porphyrins and related compounds
EP1392328B1 (fr) 2001-01-19 2009-08-12 National Jewish Medical and Research Center Medicament pour la protection dans la therapie radiologique
AU2002312194B8 (en) 2001-06-01 2008-05-15 Aeolus Sciences, Inc. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
EP1453425B1 (fr) 2001-12-03 2006-03-08 Ekos Corporation Catheter a elements multiples rayonnants a ultrasons
PT102721B (pt) * 2002-02-01 2011-01-24 Cipan Companhia Industr Prod De Antibioticos S A Compostos macrocíclicos tetrapirrólicos com rendimento quântico de oxigénio singuleto adequado à terapia fotodinâmica e processos para a sua preparação
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
AU2003237500A1 (en) 2002-06-07 2003-12-22 Duke University Substituted porphyrins
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
CA2437638A1 (fr) 2003-08-20 2005-02-20 John Robert North Therapie photodynamique
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
WO2005120572A1 (fr) 2004-06-09 2005-12-22 Qlt Inc. Thérapie photodynamique pour le traitement d'affections des glandes sébacées hyperactives en utilisant des porphyrines vertes hydrophobes appliquées localement
CA2457214A1 (fr) 2004-02-06 2005-08-06 Qlt Inc. Therapie photodynamique pour le traitement de l'acne
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
DE102005015286A1 (de) * 2005-04-04 2006-10-05 Tetrapdt Gmbh Photosensibilisatoren als Arzneimittelträger für lokale Markierung und Therapie von neoplastischem Gewebe
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
EP2494932B1 (fr) 2007-06-22 2020-05-20 Ekos Corporation Appareil pour le traitement des hémorragies intracrâniennes
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
US20090187137A1 (en) * 2007-12-14 2009-07-23 Kim Volz Ultrasound pulse shaping
US11382895B2 (en) 2008-05-23 2022-07-12 National Jewish Health Methods for treating injury associated with exposure to an alkylating species
ES2707228T3 (es) 2008-09-18 2019-04-03 Biolitec Unternehmensbeteiligungs Ii Ag Nuevo método y aplicación de porfirinas y clorinas asimétricamente meso-sustituidas para TFD
US9211283B2 (en) 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
KR20140089478A (ko) 2011-01-13 2014-07-15 큐엘티 인코포레이티드 감광제의 국소 전달용 약학 조성물 및 그의 이용
AU2013290140A1 (en) 2012-07-11 2015-01-29 Dermira, Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
US9550072B2 (en) 2012-08-03 2017-01-24 Cerca Solutions, LLC Diagnostic device, therapeutic device, and uses thereof
EP3201201B1 (fr) 2014-09-30 2022-01-26 biolitec unternehmensbeteiligungs II AG Porphyrines et chlores méso-substitués de façon spécifique pour la thérapie photodynamique
WO2016201136A1 (fr) 2015-06-10 2016-12-15 Ekos Corporation Cathéter à ultrasons
WO2020120474A1 (fr) 2018-12-10 2020-06-18 Universität Hamburg Porphyrines et chlorines glyco-substituées de façon spécifique pour une thérapie photodynamique
WO2022074014A1 (fr) 2020-10-05 2022-04-14 Biolitec Unternehmensbeteiligungs Ii Ag Composés à base de tétrapyrrole et leurs formulations pour une thérapie antimicrobienne

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2740794A (en) * 1954-07-26 1956-04-03 Exxon Research Engineering Co Synthesis of novel vanadium porphyrin
US3076813A (en) * 1957-11-13 1963-02-05 Monsanto Chemicals alpha, beta, gamma, sigma-tetra-arylporphins
US3687863A (en) * 1970-05-25 1972-08-29 Gen Telephone & Elect Optical filters containing tetraphenyl-porphins and method of making same
DE2308252A1 (de) * 1973-02-20 1974-08-22 Basf Ag Verfahren zur herstellung von mesotetraarylporphinen
US4330637A (en) * 1981-01-05 1982-05-18 Western Electric Company, Inc. Encapsulated electronic devices and encapsulating compositions
EP0127797B1 (fr) * 1983-06-03 1987-06-16 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Molécules marquées pour déterminations par immunofluorescence et procédés et produits intermédiaires pour leur préparation
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments

Also Published As

Publication number Publication date
NL300089I1 (nl) 2002-07-01
DE68906301D1 (de) 1993-06-09
IE63290B1 (en) 1995-04-05
AU611774B2 (en) 1991-06-20
US4992257A (en) 1991-02-12
NZ228225A (en) 1990-08-28
NL300089I2 (nl) 2002-08-01
IE890687L (en) 1989-09-11
CA1338737C (fr) 1996-11-26
HK129693A (en) 1993-12-03
DE10299012I1 (de) 2002-07-18
GB8805849D0 (en) 1988-04-13
JP2785033B2 (ja) 1998-08-13
DE10299012I2 (de) 2004-05-06
DE68906301T2 (de) 1993-09-30
EP0337601B1 (fr) 1993-05-05
AU611774C (en) 2002-02-21
AU3097589A (en) 1989-09-14
ES2055038T3 (es) 1994-08-16
LU90907I2 (fr) 2003-04-30
BR1100662A (pt) 1999-10-13
JPH01275528A (ja) 1989-11-06
KR890014548A (ko) 1989-10-24
ATE89002T1 (de) 1993-05-15
EP0337601A1 (fr) 1989-10-18
KR970011392B1 (ko) 1997-07-10

Similar Documents

Publication Publication Date Title
ZA891653B (en) Porphyrins and cancer treatment
AU578329B2 (en) Anti cancer treatment with porphyrins
IN170909B (fr)
NZ227131A (en) Compositions for improving cognitive function by administering 1,2-oxazole derivatives
PT582810E (pt) Novas 7-(substituidas)-8-(substituidas)-9-(substituidas)-6-desmetil-6-desoxitetraciclinas como agentes antibioticos
AU7404791A (en) Treatment of cataract with 15-keto-prostaglandin compounds
NO932954L (no) 2,4-diaminokinazolin-derivater for aa oppnaa oeket antitumoraktivitet
CA2015473A1 (fr) Derives de triphenylmethane
GR3004139T3 (fr)
IL118367A0 (en) Heteroaroyl derivatives
GR3022801T3 (en) Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity.
IL108316A0 (en) C-10 taxana derivatives and pharmaceutical compositions containing them
AU1254188A (en) Disaccharide derivatives
AU584270B2 (en) Novel derivatives of erythromycylamine
ATE153340T1 (de) Cyathane derivate und diese enthaltende nervenwachstumsfaktor produktion stimulatoren und antimikrobielle mittel
AU639322B2 (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
AU7719491A (en) Therapeutic compound
EP0551844A3 (fr)
AU6029090A (en) Improvements in or relating to organic compounds